Feb 6, 2019 by Brian FeroldiHere's Why Skyworks Solutions' Stock Is Up Big TodayShares jump even though the company reports weak results across the board and provides a downbeat outlook. What can explain the move?
Feb 6, 2019 by Brian FeroldiPaycom Software's Revenue and Profits Head in Opposite DirectionsTop-line growth remains strong, but elevated spending levels and changes to the U.S. tax code caused profitability to wane.
Feb 4, 2019 by Brian FeroldiWhy The Ultimate Software Group Is Skyrocketing TodayTraders cheer after the company announces that it is being taken private. Here's what investors need to know.
Feb 3, 2019 by Brian Feroldi3 Stocks Warren Buffett May Wish He Could BuyThe Oracle of Omaha can't touch these stocks, but you can.
Feb 3, 2019 by Brian FeroldiNIC Braces for a Challenging 2019Lower revenue projection from a key customer will be a major headwind for this software services company.
Feb 1, 2019 by Brian FeroldiIDEXX Laboratories Finishes 2018 StrongDouble-digit profit growth continues for the animal diagnostic company.
Feb 1, 2019 by Brian FeroldiHere's Why Proofpoint Is SoaringTraders cheer after the company reports upbeat fourth-quarter results. Here's what investors need to know.
Feb 1, 2019 by Brian FeroldiCullen/Frost Bankers Ends 2018 With a BangRising interest rates and steady execution help drive a double-digit gain on the bottom line.
Jan 31, 2019 by Brian FeroldiAbiomed Raises Guidance After Another Strong QuarterWorldwide demand for temporary heart pumps continues to soar.
Jan 30, 2019 by Brian FeroldiWhy Stryker Is Soaring TodayTraders cheer after the company reports upbeat fourth-quarter results and shares a bullish outlook.
Jan 30, 2019 by Brian FeroldiWhy AC Immune SA Is ImplodingShares crater after the company provides investors with terrible clinical news.
Jan 29, 2019 by Brian FeroldiHCA Healthcare Hikes Its Dividend 14%A solid end to 2018 allows management to return even more capital to shareholders.
Jan 28, 2019 by Brian FeroldiWhy Shares of Guess? Are Tanking TodaySurprise turnover in the corner office is spooking traders.
Jan 25, 2019 by Brian FeroldiAcquisitions Cause ResMed's Profit Growth to StallLavish spending on additions to the company's growing software business took a toll on net income.
Jan 24, 2019 by Brian FeroldiHow to Play It Safe in BiotechRisk-averse investors might be surprised how safe some of these companies are in one of the most volatile sectors on the market.
Jan 23, 2019 by Brian FeroldiBetter Buy: Amgen vs. Johnson & JohnsonIt's a battle between a healthcare conglomerate and the granddaddy of biotech. Which is the better choice for investors today?
Jan 23, 2019 by Brian FeroldiHere's Why Accuray Is Flying Higher TodayTraders cheer a mixed earnings report. Here's what investors need to know.
Jan 20, 2019 by Brian Feroldi3 No-Brainer Stocks I'd Buy Right NowThese rock-solid growth stocks are great buys at today's prices.
Jan 20, 2019 by Brian Feroldi5 "Technical Analysis" Charts for Long-Term InvestorsMost charts are useless, but these five can make you a better stock picker.
Jan 16, 2019 by Brian FeroldiWhy Electronics for Imaging Is Dropping TodayShares of the digital-printing company fall hard after the company provides investors with a sneak peek at its quarterly results.
